GB1462805A - Antibiotic and process for the preparation thereof - Google Patents

Antibiotic and process for the preparation thereof

Info

Publication number
GB1462805A
GB1462805A GB1656974A GB1656974A GB1462805A GB 1462805 A GB1462805 A GB 1462805A GB 1656974 A GB1656974 A GB 1656974A GB 1656974 A GB1656974 A GB 1656974A GB 1462805 A GB1462805 A GB 1462805A
Authority
GB
United Kingdom
Prior art keywords
fortimicin
antibiotic
indicated
micromonospora
spectrum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1656974A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Abbott Laboratories
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd, Abbott Laboratories filed Critical Kyowa Hakko Kogyo Co Ltd
Publication of GB1462805A publication Critical patent/GB1462805A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/224Cyclohexane rings substituted by at least two nitrogen atoms with only one saccharide radical directly attached to the cyclohexyl radical, e.g. destomycin, fortimicin, neamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1462805 Fortimicin B ABBOTT LABORATORIES and KYOWA HAKKO KOGYO CO Ltd 16 April 1974 [17 April 1973] 16569/74 Headings C2A and C2C A process for producing the antibiotic Fortimicin B comprises culturing a microorganism belonging to the genus Micromonospora having the ability to produce Fortimicin B in a nutrient medium and accumulating Fortimicin B in said medium. Suitable microorganisms are Micromonospora olivoasterospora ATCC 21819, Micromonospora olivoasterospora ATCC 31009 and Micromonospora olivoasterospora ATCC 31010. Fortimicin B has a molecular weight of 348, a formula of C 15 H 32 N 4 O 5 ,a melting point of 101-103‹ C., an optical rotation [α] D <SP>24</SP> of 22À2 (C = 1À01, H 2 O) and is characterized by (a) a u.v. spectrum as indicated in Fig. 1 (not shown), (b) an infra-red spectrum as indicated in Fig. 2 (not shown) and (e) an nmr spectrum as indicated in Fig. 3 (not shown). The antibiotic is believed to have the following chemical structure Pharmaceutically non-toxic acid addition salts of the antibiotic may be prepared by known methods. The antibiotic or acid addition salt may be admixed with an inert carrier or diluent to form a pharmaceutical or disinfectant composition.
GB1656974A 1973-04-17 1974-04-16 Antibiotic and process for the preparation thereof Expired GB1462805A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP48042696A JPS5246311B2 (en) 1973-04-17 1973-04-17

Publications (1)

Publication Number Publication Date
GB1462805A true GB1462805A (en) 1977-01-26

Family

ID=12643199

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1656974A Expired GB1462805A (en) 1973-04-17 1974-04-16 Antibiotic and process for the preparation thereof

Country Status (17)

Country Link
JP (1) JPS5246311B2 (en)
AR (1) AR201860A1 (en)
AT (1) AT329180B (en)
BE (1) BE813772A (en)
CA (1) CA1025384A (en)
CH (1) CH590925A5 (en)
DE (1) DE2418349C3 (en)
DK (1) DK137864B (en)
ES (1) ES425440A1 (en)
FR (1) FR2226159B1 (en)
GB (1) GB1462805A (en)
IN (1) IN139126B (en)
NL (1) NL157655B (en)
NO (1) NO139864C (en)
PH (1) PH12923A (en)
SE (1) SE420214B (en)
ZA (1) ZA742107B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5218888A (en) * 1975-08-01 1977-02-12 Kyowa Hakko Kogyo Co Ltd Preparation of fortimicin c
JPS6011718B2 (en) * 1976-09-23 1985-03-27 協和醗酵工業株式会社 Novel hortimycin B derivative and its production method
US4091032A (en) * 1976-09-23 1978-05-23 Abbott Laboratories 4-N-acylfortimicin B derivatives and the chemical conversion of fortimicin B to fortimicin A
JPS53141244A (en) * 1977-05-11 1978-12-08 Kyowa Hakko Kogyo Co Ltd Novel hortemycin derivatives
US4219643A (en) * 1979-03-29 1980-08-26 Abbott Laboratories Fortimicin AN
CN109897862B (en) * 2019-02-03 2020-10-02 浙江海正药业股份有限公司 Gentamicin B producing strain and preparation method and application thereof

Also Published As

Publication number Publication date
DE2418349B2 (en) 1979-08-16
NL7405105A (en) 1974-10-21
FR2226159B1 (en) 1977-07-01
CH590925A5 (en) 1977-08-31
PH12923A (en) 1979-10-10
SE420214B (en) 1981-09-21
ATA310274A (en) 1975-07-15
IN139126B (en) 1976-05-08
AT329180B (en) 1976-04-26
ES425440A1 (en) 1976-06-01
DK137864B (en) 1978-05-22
DK137864C (en) 1978-10-23
CA1025384A (en) 1978-01-31
DE2418349A1 (en) 1974-11-07
JPS49126892A (en) 1974-12-04
AU6768374A (en) 1975-10-09
DE2418349C3 (en) 1980-04-24
NO139864C (en) 1979-05-23
NO741300L (en) 1974-10-18
ZA742107B (en) 1975-04-30
FR2226159A1 (en) 1974-11-15
AR201860A1 (en) 1975-04-24
JPS5246311B2 (en) 1977-11-24
BE813772A (en) 1974-10-16
NO139864B (en) 1979-02-12
NL157655B (en) 1978-08-15

Similar Documents

Publication Publication Date Title
GB1473356A (en) Antibiotic and process for proeuction thereof
GB1491266A (en) Anti-tumor antibiotics aclacinomycins a and b
GB1453425A (en) 2-oxo-tetrahydropyran derivatives and fermentative process for producing the same
ES450333A1 (en) Tylosin derivatives and their manufacturing process
GB1426908A (en) 1-n--s--alpha-hydroxy-omega-aminoacyl- derivative of amino glycosidic antibiotics
GB1462805A (en) Antibiotic and process for the preparation thereof
US3669838A (en) Method of making antibiotics containing the aminocyclitol subunit
KR870004144A (en) Preparation of anti-tumor antibiotics (LL-E33288 complex)
US3358001A (en) Antibiotic kasugamycin
ES480405A1 (en) Novel macrolide antibiotics and preparation thereof
US3454696A (en) Antibiotics 460 and methods for their production
GB1481529A (en) Cephalosporin antibiotic substance and the production thereof
RU2001116104A (en) Vancorezmycin, a method for its preparation and its use as a medicine
GB1479179A (en) Antibiotics designated xk-88 series and process for production thereof
GB1500965A (en) Cyclic ether antibiotics
Sebek The synthesis of neomycin-C14 by Streptomyces fradiae
JPS54117478A (en) New antibiotics fortimicin kg1, kg2, and kg3, and their preparation
ES467562A1 (en) New antibiotics salts thereof process for preparing same and medical composition containing same
JPS57170189A (en) Dc-52 and its preparation
US3901877A (en) Oxamicetin and process for its production
GB1480082A (en) Cephalosporin antibiotic
JPS5466679A (en) Novel antibiotic substance fortimicin kf and fortimicin kg, and their preparation
GB1438785A (en) Antibiotics and a process for the preparation thereof
US3642985A (en) Threomycin and production thereof
KR910016936A (en) Method for preparing new mannosyl teicoplanin aglycone and mannosyl teicoplanin derivative

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee